FrancophonIA/ELRC3.0 huggingface dataset:
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) decided that Corbilta's benefits are greater than its risks and recommended that it be approved for use in the EU.
Croatian: Povjerenstvo za lijekove za primjenu kod ljudi (CHMP) pri Agenciji odlučilo je da koristi od lijeka Corbilta nadmašuju s njim povezane rizike te je preporučilo njegovo odobrenje za korištenje u Europskoj uniji.
English: Why is Corbilta approved?
Croatian: Zašto je lijek Corbilta odobren?
English: It is used to treat adults with Parkinson's disease (a progressive brain disorder that causes shaking, slow movement and muscle stiffness).
Croatian: Koristi se za liječenje odraslih bolesnika s Parkinsonovom bolesti (progresivnom bolesti mozga koja uzrokuje tresavicu, usporene pokrete i ukočenost mišića).
English: Corbilta is used in patients who are being treated with a combination of levodopa and an inhibitor of dopa decarboxylase (two standard treatments for Parkinson's disease) but are having ‘fluctuations' towards the end of the period between two doses of their medication.
Croatian: Corbilta koristi se u bolesnika koji se liječe kombinacijom levodope i inhibitora dopa dekarboksilaze (dvije standardne terapije za Parkinsonovu bolest), ali imaju „fluktuacije” prema kraju razdoblja između dvije doze lijeka.
English: • a history of neuroleptic malignant syndrome (a dangerous nervous system disorder usually caused by antipsychotic medicines) or rhabdomyolysis (breakdown of muscle fibres).
Croatian: • anamnezom neuroleptičkog malignog sindroma (opasni poremećaj živčanog sustava uzrokovanog antipsihoticima) ili rabdomiolize (razgradnja mišićnih vlakana).
English: Serious side effects which have been reported much less often include gastrointestinal haemorrhage (bleeding in the gut) and angioedema (swelling under the skin of face or limbs).
Croatian: Ozbiljne nuspojave koje su zabilježene puno češće uključuju krvarenje u gastrointestinalnom traktu (krvarenje u želucu) i angioedem (oticanje pod kožom lica ili udova).
English: The company used some of the data from Comtess/Comtan (entacapone) to support the use of Corbilta and presented data from the published literature for the use of the combination of levodopa and carbidopa.
Croatian: Tvrtka je koristila neke podatke za lijek Comtess/Comtan (entakapon) kako bi poduprla uporabu lijeka Corbilta i prikazala podatke iz objavljene literature za uporabu kombinacije levodope i karbidope.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Corbilta, including the appropriate precautions to be followed by healthcare professionals and patients.
Croatian: Na temelju tog plana u sažetak opisa svojstava lijeka kao i u uputu o lijeku za Corbilta uključene su sigurnosne informacije uključujući odgovarajuće mjere opreza kojih se zdravstveni djelatnici i bolesnici trebaju pridržavati.
English: Both carbidopa and entacapone block some of the enzymes that are involved in the breakdown of levodopa in the body: carbidopa blocks the enzyme dopa decarboxylase, and entacapone blocks the enzyme catechol-O-methyl transferase (COMT).
Croatian: I karbidopa i entakapon blokiraju neke od enzima koji su uključeni u razgradnju levodope u tijelu: karbidopa blokira enzim dopa dekarboksilazu, a entakapon blokira enzim katehol-O-metil transferazu (COMT).
English: What benefits of Corbilta have been shown in studies?
Croatian: Koje su koristi lijeka Corbilta dokazane u ispitivanjima?
English: The most common side effects with Corbilta (seen in more than 1 patient in 10) are dyskinesia (uncontrollable movements), aggravated Parkinsonism (worsening of Parkinson's disease), nausea (feeling sick) and harmless urine discoloration.
Croatian: Najčešće nuspojave lijeka Corbilta (uočene kod više od 1 na 10 osoba) su diskinezija (nekontrolirani pokreti), pogoršani parkinsonizam (pogoršanje Parkinsonove bolesti), mučnina i bezopasna promjena boje mokraće.
English: How is Corbilta used?
Croatian: Kako se Corbilta koristi?
English: The company carried out ‘bioequivalence' studies to show that taking Corbilta produces the same levels of levodopa, carbidopa and entacapone in the blood as taking separate tablets containing entacapone and the combination of levodopa and carbidopa.
Croatian: Tvrtka je provela studije bioekvivalencije kako bi pokazala da uzimanje lijeka Levodopa/Carbidopa/Entacapone proizvodi iste razine lijekova levodopa, karbidopa i entakapona u krvi kao i uzimanje zasebnih tableta koje sadrže entakapon i kombinaciju levodope i karbidope.
English: For more information about treatment with Corbilta, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o terapiji lijekom Corbilta pročitajte u uputama o lijeku (također dio EPAR-a), odnosno obratite se svom liječniku ili ljekarniku.
English: • phaeochromocytoma (a tumour of the adrenal gland);
Croatian: • feokromocitomom (tumorom nadbubrežne žlijezde);
English: For the full list of all side effects reported with Corbilta, see the package leaflet.
Croatian: Potpuni popis nuspojava koje su zabilježene s Corbilta potražite u uputi o lijeku.
English: For practical information about using Corbilta, patients should read the package leaflet or contact their doctor or pharmacist.
Croatian: Praktične informacije o korištenju lijeka Corbilta pročitajte u uputi o lijeku, odnosno obratite se svom liječniku ili ljekarniku.
English: How does Corbilta work?
Croatian: Kako Corbilta djeluje?
English: See the summary of product characteristics (also part of the EPAR) for full details.
Croatian: Za više informacija pogledajte Sažetak opisa svojstava lijeka (koji je također dio EPAR-a).
English: You can take Kinzalmono with or without food.
Croatian: Možete uzimati Kinzalmono sa ili bez hrane.
English: It is important that you take Kinzalmono every day until your doctor tells you otherwise.
Croatian: Važno je uzimati Kinzalmono svaki dan, dok Vam liječnik ne kaže drugačije.
English: One blister contains 7 tablets.
Croatian: Jedan blister sadrži 7 tableta.
English: Date of last renewal: 16 December 2008
Croatian: Datum posljednje obnove odobrenja: 16. prosinca 2008.
English: See also information under the heading “Do not take Kinzalmono”.
Croatian: Vidjeti također informacije pod naslovom „Nemojte uzimati Kinzalmono“
English: NN: {number} [national reimbursement number or other national number identifying the medicinal Product]
Croatian: NN: {broj} [nacionalni broj s liste lijekova ili drugi nacionalni broj za identifikaciju lijeka]
English: What Kinzalmono is and what it is used for
Croatian: Što je Kinzalmono i za što se koristi
English: • If you are taking an ACE-inhibitor or aliskiren (see also information under the headings “Do not take Kinzalmono” and “Warnings and precautions”).
Croatian: • Ako uzimate ACE inhibitor ili aliskiren (vidjeti također informacije pod naslovima „Nemojte uzimati Kinzalmono“ i „Upozorenja i mjere opreza“).
English: If you have the impression that the effect of Kinzalmono is too strong or too weak, talk to your doctor or pharmacist.
Croatian: Ako mislite da je učinak Kinzalmonoa prejak ili preslab, razgovarajte sa svojim liječnikom ili ljekarnikom.
English: Other medicines and Kinzalmono
Croatian: Drugi lijekovi i Kinzalmono
English: Your doctor will normally advise you to stop taking Kinzalmono before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Kinzalmono.
Croatian: Liječnik će Vam obično savjetovati da prestanete uzimati Kinzalmono prije nego ostanete trudni ili čim saznate da ste trudni te će Vam savjetovati uzimanje drugog lijeka umjesto Kinzalmonoa.
English: Patients with rare hereditary problems of fructose intolerance should not take Kinzalmono.
Croatian: Bolesnici s rijetkim nasljednim poremećajem nepodnošenja fruktoze ne bi trebali uzimati Kinzalmono.
English: In case of surgery or anaesthesia, you should tell your doctor that you are taking Kinzalmono.
Croatian: U slučaju kirurškog zahvata ili anestezije, trebate obavijestiti svog liječnika da uzimate Kinzalmono.
English: Adverse reactions have been ranked under headings of frequency using the following convention: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000)
Croatian: Nuspojave su poredane po kategorijama učestalosti prema sljedećem pravilu: vrlo često (≥1/10); često (≥1/100 do <1/10); manje često (≥1/1 000 do <1/100); rijetko (≥1/10 000 do <1/1000); vrlo rijetko (<1/10 000).
English: Talk to your doctor before taking Kinzalmono if you are suffering or have ever suffered from any of the following conditions or illnesses:
Croatian: Obratite se svom liječniku prije nego uzmete Kinzalmono ako imate ili ste ikada imali neko od sljedećih stanja ili bolesti:
English: What Kinzalmono is and what it is used for What you need to know before you take Kinzalmono How to take Kinzalmono
Croatian: Što je Kinzalmono i za što se koristi Što morate znati prije nego počnete uzimati Kinzalmono
English: Do not take Kinzalmono
Croatian: Nemojte uzimati Kinzalmono
English: If you forget to take Kinzalmono
Croatian: Ako ste zaboravili uzeti Kinzalmono
English: Talk to your doctor before taking Kinzalmono:
Croatian: Obratite se svom liječniku prije nego uzmete Kinzalmono:
English: Some people feel dizzy or tired when taking Kinzalmono.
Croatian: Neki ljudi osjećaju omaglicu ili umor kada uzimaju Kinzalmono.
English: Volume and/or sodium depletion should be corrected prior to administration of Kinzalmono.
Croatian: Deplecija volumena i/ili natrija se mora korigirati prije primjene Kinzalmonoa.
English: There are no adequate data from the use of Kinzalmono in pregnant women.
Croatian: Ne postoje odgovarajući podaci o primjeni Kinzalmonoa u trudnica.
English: The overall incidence of adverse reactions reported with telmisartan (was usually comparable to placebo (41.4 % vs 43.9 %) in controlled trials in patients treated for hypertension.
Croatian: Ukupna incidencija nuspojava zabilježenih s telmisartanom bila je uobičajeno usporediva s placebom (41,4 % u odnosu na 43,9 %) u kontroliranim ispitivanjima u bolesnika liječenih zbog hipertenzije.
English: You should consult with your doctor if you need to adjust the dose of your other medicine while taking Kinzalmono.
Croatian: Potrebno je posavjetovati se s liječnikom ako trebate prilagodbu doze drugih lijekova koje uzimate istodobno s Kinzalmonom.
English: Kinzalmono is not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed, especially if your baby is newborn, or was born prematurely.
Croatian: Kinzalmono se ne preporučuje dojiljama te Vaš liječnik može odabrati drugo liječenje za Vas ako želite dojiti, osobito ako je Vaše dijete novorođenče ili je prerano rođeno.
English: At the beginning of the preventive therapy with Kinzalmono 80 mg, blood pressure should be frequently monitored.
Croatian: Na početku preventivnog liječenja s Kinzalmonom od 80 mg, krvni tlak treba redovito pratiti.
English: There is no experience regarding the administration of Kinzalmono in patients with recent kidney transplantation.
Croatian: Ne postoji iskustvo u vezi primjene Kinzalmonoa u bolesnika kojima je nedavno transplantiran bubreg.
English: What you need to know before you take Kinzalmono
Croatian: Što morate znati prije nego počnete uzimati Kinzalmono
English: Such conditions should be corrected before the administration of Kinzalmono.
Croatian: Takva stanja moraju se korigirati prije primjene Kinzalmonoa.
English: Kinzalmono is used to treat essential hypertension (high blood pressure) in adults.
Croatian: Kinzalmono se primjenjuje u liječenju esencijalne hipertenzije (visoki krvni tlak) u odraslih osoba.
English: Kinzalmono may be less effective in lowering the blood pressure in black patients.
Croatian: Kinzalmono može biti manje učinkovit u snižavanju krvnog tlaka u bolesnika crne rase.
English: As with other medicinal products acting on the renin-angiotensin-aldosterone-system, telmisartan may provoke hyperkalaemia (see section 4.4).
Croatian: Poput ostalih lijekova koji djeluju na sustav renin-angiotenzin-aldosteron, telmisartan može izazvati hiperkalijemiju (vidjeti dio 4.4).
English: Kinzalmono belongs to a class of medicines known as angiotensin II receptor antagonists.
Croatian: Kinzalmono pripada skupini lijekova poznatih kao antagonisti receptora angiotenzina II.
English: When driving vehicles or operating machinery it should be taken into account that dizziness or drowsiness may occasionally occur when taking antihypertensive therapy such as Kinzalmono.
Croatian: Prilikom upravljanja vozilima ili strojevima, povremeno može doći do pojave omaglice ili pospanosti, kada se uzima antihipertenzivna terapija poput Kinzalmonoa.
English: What Kinzalmono contains
Croatian: Što Kinzalmono sadrži
English: Because no information is available regarding the use of Kinzalmono during breast-feeding, Kinzalmono is not recommended and alternative treatments with better established safety profiles during breast-feeding are preferable, especially while nursing a newborn or preterm infant.
Croatian: Budući da ne postoje dostupni podaci o primjeni Kinzalmonoa tijekom dojenja, primjena Kinzalmonoa se ne preporučuje i prednost se daje drugim lijekovima s bolje utvrđenim sigurnosnim profilima tijekom dojenja, osobito tijekom razdoblja dojenja novorođenčeta ili nedonoščeta.
English: Telmisartan tablets are for once-daily oral administration and should be taken with liquid with or without food.
Croatian: Telmisartan tablete primjenjuju se peroralno jedanput na dan i trebaju se uzimati s tekućinom, sa ili bez hrane.
English: The effect of Kinzalmono may be reduced when you take NSAIDs (non steroidal anti-inflammatory medicines, e.g. aspirin or ibuprofen) or corticosteroids.
Croatian: Učinak Kinzalmonoa se može smanjiti kada uzimate NSAIL (nesteroidne protupalne lijekove, npr. aspirin ili ibuprofen) ili kortikosteroide.
English: Kinzalmono may increase the blood pressure lowering effect of other medicines used to treat high blood pressure or of medicines with blood pressure lowering potential (e.g. baclofen, amifostine).
Croatian: Kinzalmono može povećati učinak snižavanja krvnog tlaka drugih lijekova koji se primjenjuju u liječenju visokog krvnog tlaka ili lijekova s potencijalnim učincima na snižavanje krvnog tlaka (npr. baklofen, amifostin).
English: If you are intolerant to some sugars, consult your doctor before taking Kinzalmono.
Croatian: Ako ne podnosite neke šećere, posavjetujte se sa svojim liječnikom prije uzimanja Kinzalmonoa.
English: For reduction of cardiovascular events, the usual dose of Kinzalmono is one 80 mg tablet once a day.
Croatian: Za smanjivanje kardiovaskularnih događaja, uobičajena doza Kinzalmonoa je jedna tableta od 80 mg, jedanput na dan.
English: Kinzalmono is also used to reduce cardiovascular events (i.e. heart attack or stroke) in adults who are at risk because they have a reduced or blocked blood supply to the heart or legs, or have had a stroke or have high risk diabetes.
Croatian: Kinzalmono se također primjenjuje za smanjivanje kardiovaskularnih događaja (tj. srčanog udara ili moždanog udara) u rizičnih odraslih osoba koji imaju smanjenu ili prekinutu opskrbu krvlju srca ili nogu, ili su imali moždani udar, ili imaju šećernu bolest s visokim rizikom za oštećenje organa.
English: The concomitant use of Kinzalmono with aliskiren-containing products is contraindicated in patients with diabetes mellitus or renal impairment (GFR < 60 ml/min/1.73 m2) (see sections 4.5, and 5.1).
Croatian: Istodobna primjena Kinzalmona s lijekovima koji sadrže aliskiren kontraindicirana je u bolesnika sa šećernom bolešću ili oštećenjem bubrega (GFR < 60 ml/min/1,73 m2) (vidjeti dijelove 4.5 i 5.1).
English: Symptomatic hypotension, especially after the first dose of Kinzalmono, may occur in patients who are volume and/or sodium depleted by vigorous diuretic therapy, dietary salt restriction, diarrhoea, or vomiting.
Croatian: Simptomatska hipotenzija, osobito nakon prve doze Kinzalmonoa, može se pojaviti u bolesnika koji imaju depleciju volumena i/ili natrija zbog snažne terapije diureticima, prehrane s ograničenim unosom soli, proljeva ili povraćanja.
English: Remove your Kinzalmono tablet from the blister only directly prior to intake.
Croatian: Izvadite Kinzalmono tabletu iz blistera neposredno prije unosa.
English: This applies especially to the medicines listed below taken at the same time with Kinzalmono:
Croatian: Ovo se osobito odnosi na lijekove koji su navedeni u nastavku, a uzimaju se istovremeno s Kinzalmonom:
English: Children and adolescents The use of Kinzalmono in children and adolescents up to the age of 18 years is not recommended.
Croatian: Djeca i adolescenti Primjena Kinzalmonoa u djece i adolescenata do dobi od 18 godina se ne preporučuje.
English: Kinzalmono is not to be given to patients with cholestasis, biliary obstructive disorders or severe hepatic impairment (see section 4.3) since telmisartan is mostly eliminated with the bile.
Croatian: Kinzalmono se ne smije davati bolesnicima s kolestazom, bilijarnom opstrukcijom ili teškim oštećenjem jetrene funkcije (vidjeti dio 4.3), s obzirom da se telmisartan uglavnom eliminira putem žuči.
English: The safety and efficacy of Kinzalmono in children and adolescents aged below 18 years have not been established.
Croatian: Sigurnost i djelotvornost Kinzalmonoa u djece i adolescenata u dobi ispod 18 godina nisu ustanovljene.
English: In preclinical studies, no effects of Kinzalmono on male and female fertility were observed.
Croatian: U nekliničkim ispitivanjima učinci Kinzalmonoa na plodnost muškaraca i žena nisu uočeni.
English: Kinzalmono contains sorbitol.
Croatian: Kinzalmono sadrži sorbitol.
English: How to take Kinzalmono
Croatian: Kako uzimati Kinzalmono
English: When Kinzalmono is used in patients with impaired renal function, periodic monitoring of potassium and creatinine serum levels is recommended.
Croatian: Kada se Kinzalmono primjenjuje u bolesnika s poremećenom funkcijom bubrega, preporučuje se povremeno pratiti vrijednosti kalija i kreatinina u serumu.
English: • Diuretics ('water tablets'), especially if taken in high doses together with Kinzalmono, may lead to excessive loss of body water and low blood pressure (hypotension).
Croatian: • Diuretici ('tablete za mokrenje'), osobito ako se uzimaju visoke doze zajedno s Kinzalmonom, mogu dovesti do prekomjernog gubitka vode u tijelu te niskog krvnog tlaka (hipotenzija).
English: Kinzalmono is contraindicated in patients with severe hepatic impairment (see section 4.3).
Croatian: Kinzalmono je kontraindiciran u bolesnika s teškim oštećenjem funkcije jetre (vidjeti dio 4.3).
English: If any of the above applies to you, tell your doctor or pharmacist before taking Kinzalmono.
Croatian: Ako se nešto od prethodno navedenog odnosi na Vas, obavijestite liječnika ili ljekarnika prije početka uzimanja Kinzalmonoa.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS Unit dose blister (28 x 1 tablets pack)
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP Blister djeljiv na jedinične doze (pakiranje s 28 x 1 tabletom)
English: Kinzalmono blocks the effect of angiotensin II so that the blood vessels relax, and your blood pressure is lowered.
Croatian: Kinzalmono blokira učinak angiotenzina II, tako da se krvne žile šire, a krvni tlak snižava.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Kinzalmono 20 mg tablets
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV Kinzalmono 20 mg tablete
English: If you take more Kinzalmono than you should If you accidentally take too many tablets, contact your doctor, pharmacist, or your nearest hospital emergency department immediately.
Croatian: Ako ste slučajno uzeli previše tableta, odmah se obratite svom liječniku, ljekarniku ili u hitnu službu najbliže bolnice.
English: How to store Kinzalmono
Croatian: Kako čuvati Kinzalmono
English: Eye disorders: Rare:
Croatian: Poremećaji oka Rijetko:
English: Possible side effects of Kinzalmono
Croatian: Moguće nuspojave Kinzalmonoa
English: Kinzalmono 20 mg tablets Pack sizes: Blister with 14, 28, 56 or 98 tablets.
Croatian: Kinzalmono 20 mg tablete Veličine pakiranja: Blister s 14, 28, 56, ili 98 tableta.
English: Kinzalmono may also be used in combination with diuretics ('water tablets') such as hydrochlorothiazide which has been shown to have an additive blood pressure lowering effect with Kinzalmono.
Croatian: Kinzalmono se također može primjenjivati u kombinaciji s diureticima (tablete za mokrenje), kao što je hidroklorotiazid za koji se pokazalo da ima dodatan učinak snižavanja krvnog tlaka s Kinzalmonom.
English: Kinzalmono is not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).
Croatian: Kinzalmono se ne preporučuje u ranoj trudnoći i ne smije se uzimati ako ste trudni dulje od 3 mjeseca jer može izazvati teška oštećenja Vašeg djeteta ako se primjenjuje u ovom stadiju (vidjeti dio o trudnoći).
English: For treatment of high blood pressure, the usual dose of Kinzalmono for most patients is one 40 mg tablet once a day to control blood pressure over the 24 hour period.
Croatian: Za terapiju povišenog krvnog tlaka uobičajena doza Kinzalmonoa za većinu bolesnika je jedna tableta od 40 mg jedanput na dan za kontrolu krvnog tlaka tijekom 24 sata.
English: Kinzalmono should be used only with caution in patients with mild to moderate hepatic impairment.
Croatian: Kinzalmono se treba primjenjivati isključivo s oprezom u bolesnika s blagim do umjerenim oštećenjem jetrene funkcije.
English: Kinzalmono 40 mg and 80 mg tablets 4 years
Croatian: Kinzalmono 40 mg i 80 mg tablete 4 godine
English: Kinzalmono 20 mg tablets 3 years
Croatian: Kinzalmono 20 mg tablete 3 godine
English: (It is also better to avoid Kinzalmono in early pregnancy - see pregnancy section.)
Croatian: • Ako ste dulje od 3 mjeseca trudni (također je bolje izbjegavati Kinzalmono u ranoj trudnoći vidjeti dio o trudnoći).
English: Kinzalmono is not recommended in early pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.
Croatian: Kinzalmono se ne preporučuje u ranoj trudnoći te se ne smije uzimati ako ste trudni dulje od 3 mjeseca jer može izazvati teška oštećenja djeteta ako se primjenjuje nakon trećeg mjeseca trudnoće.
English: Kinzalmono is available in blister packs containing 14, 28, 56 or 98 tablets.
Croatian: Kinzalmono je dostupan u blister pakiranjima od 14, 28, 56 ili 98 tableta.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 16 December 1998
Croatian: DATUM PRVOG ODOBRENJA / DATUM OBNOVE ODOBRENJA
English: Kinzalmono 40 mg tablets White oblong tablets of 3.8 mm engraved with the code number '51H' on one side.
Croatian: Kinzalmono 40 mg tablete Bijele, duguljaste tablete od 3,8 mm s utisnutom oznakom „51H“ na jednoj strani.
English: Kinzalmono 80 mg tablets White oblong tablets of 4.6 mm engraved with the code number '52H' on one side.
Croatian: Kinzalmono 80 mg tablete Bijele, duguljaste tablete od 4,6 mm s utisnutom oznakom „52H“ na jednoj strani.
English: Kinzalmono 40 mg tablets
Croatian: Kinzalmono 40 mg tablete
English: INFORMATION IN BRAILLE Kinzalmono 20 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Kinzalmono 20 mg
English: INFORMATION IN BRAILLE Kinzalmono 80 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Kinzalmono 80 mg
English: INFORMATION IN BRAILLE Kinzalmono 40 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Kinzalmono 40 mg